Abstract
In this chapter we discuss about drugs that have action against susceptible bacteria for which most of the other common antibiotics have lost their action. Most of these antibiotics such as the glycopeptide and the polypeptide groups are obtained from microbial sources. Polypeptide antibiotics are reserved as a last option for many indications due to their renal and other systemic toxicities. They are mostly used in topical formulation on skin and mucous membrane to minimize the side effects. Urinary antiseptics, namely nitrofurantoin and methanamine are time tested drugs for urinary tract infection with minimal side effects. The principles of management of sexually transmitted disease and their various clinical presentations along with the pharmacotherapy for each type are discussed finally.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Blaskovich MAT, Hansford KA, Butler MS, Jia Z, Mark AE, Cooper MA (2018) Developments in glycopeptide antibiotics. ACS Infect Dis 4:715–735
Deck DH, Winston LG (2013) Miscellaneous antimicrobial agents; disinfectants, antiseptics, & sterilants. In: Katzung BG, Trevor AJ (eds) Basic & clinical pharmacology, 13th edn. McGraw-Hill, New York, pp 865–873
MacDougall C, Chambers HF (2011) Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Brunton LL, Chabner BA, Knollmann BC (eds) Goodman and Gilman’s pharmacological basis of therapeutics, 12th edn. McGraw-Hill Medical, New York, pp 1521–1549
Markle W, Conti T, Kad M (2013) Sexually transmitted diseases. Prim Care 40:557–587
Shakti L, Veeraraghavan B (2015) Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario. Indian J Med Microbiol 33:477–481
Wagenlehner FME, Brockmeyer NH, Discher T, Friese K, Wichelhaus TA (2016) The presentation, diagnosis, and treatment of sexually transmitted infections. Dtsch Arztebl Int 113:11–22
Workowski KA, Bolan GA (2015) Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep Morb 64:1–137
Zeng D, Debabov D, Hartsell TL, Cano RJ, Adams S, Schuyler JA, McMillan R, Pace JL (2016) Approved glycopeptide antibacterial drugs: mechanism of action and resistance. Cold Spring Harb Perspect Med 6:a026989
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ananthy, V. (2021). Miscellaneous Antimicrobial Agents. In: Paul, A., Anandabaskar, N., Mathaiyan, J., Raj, G.M. (eds) Introduction to Basics of Pharmacology and Toxicology. Springer, Singapore. https://doi.org/10.1007/978-981-33-6009-9_59
Download citation
DOI: https://doi.org/10.1007/978-981-33-6009-9_59
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6008-2
Online ISBN: 978-981-33-6009-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)